-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $285K, a 1681% increase year-over-year.
- Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$116K, a 108% decline year-over-year.
- Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$34K, a 101% decline from 2022.
- Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was $3.84M, a 52.1% decline from 2021.
- Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2021 was $8.01M, a 95.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)